Tacrolimus Capsule, Extended Release
Product Images NDC 69238-2780

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tacrolimus (NDC 69238-2780). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chem Structure (Tacrolimus Extended Release Capsules 1)

Chemical structure of tacrolimus, illustrating its complex macrolide lactone framework with various functional groups including hydroxyl, methoxy, and carbonyl moieties, depicted with stereochemistry.*

FDA Label Image

Figure 1 (Tacrolimus Extended Release Capsules 2)

A chart illustrating the pharmacokinetics (PK) of Tacrolimus when co-administered with ketoconazole and rifampin. It presents the geometric mean ratio of test to reference values with 90% confidence intervals for Cmax and AUC. The x-axis is logarithmic and spans from 0.1 to 10, comparing Tacrolimus ER with co-administered drugs against Tacrolimus ER alone, with treatments dosed over several days.*

FDA Label Image

Figure 2 (Tacrolimus Extended Release Capsules 3)

A chart presenting the pharmacokinetics (PK) of Tacrolimus when co-administered with several drugs including telapravir, boceprevir, magnesium-aluminum hydroxide, voriconazole, and posaconazole. It displays geometric mean ratios of Cmax and AUC with 90% confidence intervals comparing test (Tacrolimus immediate release plus co-administered drug) to reference (Tacrolimus immediate release alone). Dosages and administration schedules of the co-administered drugs are also listed.*

FDA Label Image

0-5 Carton (Tacrolimus Extended Release Capsules 4)

Tacrolimus Extended-Release Capsules 0.5 mg per capsule, oral extended-release capsules, distributed by Amneal Pharmaceuticals LLC. The label indicates a package of 30 capsules (3 blister cards with 10 capsules each). It features dosage instructions stating once-daily use and includes a medication guide notice. The packaging also states the product is not child-resistant and provides storage instructions and inactive ingredient information.*

FDA Label Image

1mg Carton (Tacrolimus Extended Release Capsules 5)

Packaging label for Tacrolimus Extended-Release Capsules, 1 mg per capsule, oral extended-release capsule dosage form. The label indicates a quantity of 30 capsules in blister cards, distributed by Amneal Pharmaceuticals LLC. The package includes storage instructions, inactive ingredients, and a notice that the unit-dose package is not child-resistant.*

FDA Label Image

5mg Carton (Tacrolimus Extended Release Capsules 6)

Packaging label for Tacrolimus Extended-Release Capsules 5 mg per capsule by Amneal Pharmaceuticals NY LLC. It is an oral prescription drug with a 30-capsule count, packaged in three blister cards containing 10 capsules each. The label includes usage instructions, storage conditions, and a warning that the unit-dose package is not child-resistant.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.